Citadel Advisors’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
114,267
-134,565
| -54% | -$1.19M | ﹤0.01% | 3294 |
|
|
2025
Q1 | $1.86M | Buy |
248,832
+246,343
| +9,897% | +$1.85M | ﹤0.01% | 2661 |
|
|
2024
Q4 | $20.8K | Sell |
2,489
-65,420
| -96% | -$546K | ﹤0.01% | 5642 |
|
|
2024
Q3 | $471K | Sell |
67,909
-37,329
| -35% | -$259K | ﹤0.01% | 3848 |
|
|
2024
Q2 | $516K | Buy |
105,238
+104,913
| +32,281% | +$514K | ﹤0.01% | 3747 |
|
|
2024
Q1 | $1.89K | Sell |
325
-334,452
| -100% | -$1.94M | ﹤0.01% | 5877 |
|
|
2023
Q4 | $2.19M | Buy |
334,777
+167,107
| +100% | +$1.09M | ﹤0.01% | 2322 |
|
|
2023
Q3 | $808K | Buy |
167,670
+139,229
| +490% | +$671K | ﹤0.01% | 3256 |
|
|
2023
Q2 | $145K | Sell |
28,441
-2,745
| -9% | -$14K | ﹤0.01% | 4586 |
|
|
2023
Q1 | $172K | Sell |
31,186
-77,674
| -71% | -$427K | ﹤0.01% | 4685 |
|
|
2022
Q4 | $500K | Buy |
+108,860
| New | +$500K | ﹤0.01% | 3849 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6822 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7030 |
|
|
2022
Q1 | – | Sell |
-23,813
| Closed | -$207K | – | 7243 |
|
|
2021
Q4 | $207K | Sell |
23,813
-5,165
| -18% | -$44.9K | ﹤0.01% | 5446 |
|
|
2021
Q3 | $270K | Buy |
28,978
+812
| +3% | +$7.57K | ﹤0.01% | 5116 |
|
|
2021
Q2 | $361K | Sell |
28,166
-129,305
| -82% | -$1.66M | ﹤0.01% | 5031 |
|
|
2021
Q1 | $1.45M | Buy |
+157,471
| New | +$1.45M | ﹤0.01% | 3540 |
|
|
2020
Q1 | – | Sell |
-2,606
| Closed | -$16K | – | 5403 |
|
|
2019
Q4 | $16K | Buy |
+2,606
| New | +$16K | ﹤0.01% | 4533 |
|